SERTAD1 and experimental autoimmune encephalomyelitis: In vitro, SERTAD1 knockout was associated with decreased IL-1β and IL-18 secretion, while in vivo loss of SERTAD1 attenuated peritonitis and experimental autoimmune encephalomyelitis (EAE) (44).